Over the last two years, representatives from the UK’s stroke research community have been working, in a collaboration led by the NC3Rs, to improve the welfare and increase the scientific value of rodent models of stroke. The findings from the collaboration - The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments) have been published in the Journal of Cerebral Bloodflow and Metabolism.
- (-) Remove Information on drugs and diseases filter Information on drugs and diseases
- (-) Remove Ethics filter Ethics
- (-) Remove Cardiology filter Cardiology
- (-) Remove Equine filter Equine
- (-) Remove Avian filter Avian
- (-) Remove Portals and Websites filter Portals and Websites
Discipline tool
General Database Information
The use of animals in scientific research remains a vital tool in improving our understanding of how biological systems work both in health and disease, and in the development of new medicines, treatments and technologies. Underpinning this research is a strong commitment to maintaining a rigorous regulatory system which ensures that animal research is carried out only where no practicable alternative exists and under controls which keep suffering to a minimum. This is achieved through robustly applying the principles of the 3Rs to all research proposals involving the use of animals.
The EURL ECVAM DataBase service on ALternative Methods (DB-ALM).
Guidlines from the British Psychological Society's Standing Advisory Committee on the Welfare of Animals in Psychology. This was developed in cooperation with EPS.
Humane Endpoints Website is provided by 3Rs-Centre Utrecht Life Sciences, gives insight into the recognition and application of humane endpoints in rodents. The website contributes to refinement, the prevention of unnecessary suffering in laboratory animals, by offering information, videos and photographs of rodent species. In addition, the website provides free training modules (accessible after registration). The site is currently available in EN, NL and FR. DE and ES will follow soon.